oncology
MSD poised to acquire viral immuno-oncology firm Viralytics for $394m
February 21, 2018Research and Development, Sales and Marketing Cancer, MSD, Merck, Viralytics, acquisition, keytruda, oncology, pharma
MSD, known as Merck in the US, has announced it is to buy Australian viral immuno-oncology firm Viralytics for $394 …
Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health
February 16, 2018Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma
Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …
Old anti-drinking drug shows potential as cancer treatment
December 7, 2017Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical
Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …
Access to Innovation: Beyond a ‘pharma-only’ approach
October 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology
Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
EMA responds to criticism of its cancer drug approvals
October 17, 2017Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical
The EMA received a broadside just less than two week ago from a group of researchers that had studied data …
57% of cancer drugs uses approved by EMA show no benefit
October 5, 2017Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical
A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …
The September 2017 issue of Pharmafocus is now live!
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma
The September edition of Pharmafocus is now available – click here to read online.
Takeda reveals collaboration aimed at bolstering oncology pipeline
August 8, 2017Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …
Investigational antibody boosts chemotherapy’s cancer-killing potential
June 29, 2017Research and Development CFH, Cancer, oncology, rituximab
A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …
New targeted therapy promises strong response rate across 17 cancer types
June 5, 2017Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology
Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
ICR track cancer to ‘carbon date’ progression
May 11, 2017Research and Development Cancer, ICR, bowel cancer, oncology
The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease …
Quarter of cancer patients visit GP three times with no diagnosis
April 25, 2017Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …
Immunotherapy: The three major treatments that are changing cancer prognoses
March 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq
The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
Takeda discusses the importance of patient-focused market access
February 3, 2017Medical Communications, Sales and Marketing Takeda, oncology
With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …
Two-decade-long prostate cancer study finds antiandrogen improves survival
February 2, 2017Research and Development antiandrogen, oncology, prostate cancer
Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …
